(RTTNews) - Novavax (NVAX) has filed for authorization with Health Canada for 2024-2025 Formula COVID-19 vaccine or NVX-CoV2705 for individuals aged 12 and older. Novavax plans to have its vaccine ...

Novavax, Inc. (NASDAQ:NVAX) shares are moving higher on Monday. Here’s what you need to know. What To Know: The company announced on July 2 that it has filed for authorization with Health Canada for ...

GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, ...

Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced ...

Five years ago, Novavax (NASDAQ: NVAX) was a little-known clinical-stage biotech whose leading pipeline candidate was an influenza vaccine. Then came the pandemic. The company quickly grew in ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...

Novavax (NVX-CoV2373) is a brand-name vaccine that’s prescribed to help prevent COVID-19. As with other drugs, Novavax can cause side effects, such as pain or swelling at the injection site. Novavax ...